• iconNews
  • videos
  • entertainment
  • Home
  • News
    • UK News
    • US News
    • Australia
    • Ireland
    • World News
    • Weird News
    • Viral News
    • Sport
    • Technology
    • Science
    • True Crime
    • Travel
  • Entertainment
    • Celebrity
    • TV & Film
    • Netflix
    • Music
    • Gaming
    • TikTok
  • LAD Originals
    • Say Maaate to a Mate
    • Daily Ladness
    • Lad Files
    • UOKM8?
    • FreeToBe
    • Extinct
    • Citizen Reef
  • Advertise
  • Terms
  • Privacy & Cookies
  • LADbible Group
  • UNILAD
  • SPORTbible
  • GAMINGbible
  • Tyla
  • UNILAD Tech
  • FOODbible
  • License Our Content
  • About Us & Contact
  • Jobs
  • Latest
  • Topics A-Z
  • Authors
Facebook
Instagram
X
Threads
Snapchat
TikTok
YouTube

LAD Entertainment

YouTube

LAD Stories

Submit Your Content
Brain cancer vaccine successfully prolongs patients' survival during Phase 3 trials

Home> News

Updated 04:13 25 Nov 2022 GMTPublished 00:57 25 Nov 2022 GMT

Brain cancer vaccine successfully prolongs patients' survival during Phase 3 trials

Some patients with aggressive tumours have now survived for months or even years longer than their prognosis, thanks to the new drug.

Rachel Lang

Rachel Lang

A trial vaccine for patients with aggressive brain cancer are living even longer, with experts praising the new inoculation as offering 'fresh hope' to those suffering.

Vaccine DCVax-®L is currently in Phase 3 trials at London's King’s College Hospital.

The incredible drug uses a patients’ own immune cells to target a type of cancer called glioblastoma.

The vaccine works by helping the body's immune system recognise and attack the deadly cancer cells.

Advert

The drug is now vastly improving the prognosis of cancer sufferers, with some living for months or even years longer than initially projected.

Julian Claxton / Alamy

The results, published in the Journal of American Medical Association Oncology, had Professor Keyoumars Ashkan of Neurosurgery at King’s College Hospital singing the praises of the new vaccine.

"Immunotherapy is a very promising approach for treating cancer, and the final results of this Phase 3 trial, now unblinded and published, offers fresh hope to patients battling with glioblastoma," he said, as per a King's College statement.

"The vaccine was shown to prolong life, and interestingly so in patients traditionally considered to have poorer prognosis."

Advert

Professor Ashkan, who is also the European Chief Investigator of the clinical trial, revealed they are seeing brilliant results in 'older patient groups' and for those of whom 'radical surgery was not possible'.

"I am optimistic we can build upon this going forward; investigating the combination of DCVax-®L with other emerging therapies for glioblastomas," he said.

"The long-term survivor group in particular has the potential to further teach us about the basic biology of glioblastomas, given that many patients in this group did not have the usual expected characteristics for good outcomes."

An MRI scan of a brain. Read more: mohamed abdelrazek / Alamy.
An MRI scan of a brain. Read more: mohamed abdelrazek / Alamy.

He added: "Applying the same technology to develop treatments for other forms of brain tumours will be the natural next step."

Advert

All of the participants in the trial underwent the standard treatment for glioblastoma of surgery followed by radiotherapy and chemotherapy.

Nigel French from Kent was diagnosed with a glioblastoma in 2015 after suffering a seizure in his sleep.

He was referred to King's Hospital for surgery and took part in the DCVax-®L trial.

Seven years later, he is still in remission.

Mr French revealed that he is thankful to have had the opportunity to trial the vaccine.

Advert

"I’m very grateful to the team at King’s for offering me this lifeline," he said.

"Although I can’t be certain as to whether I received DCVax-®L or the placebo, I believe the treatment I received, along with remaining positive, saved my life."

Featured Image Credit: Panther Media GmbH / Alamy. Klaus Ohlenschlaeger / Alamy.

Topics: Health, Science, News

Rachel Lang
Rachel Lang

Rachel Lang is a Digital Journalist at LADbible. During her career, she has interviewed Aussie PM Malcolm Turnbull in the lead up to the 2016 federal election, ran an editorial campaign on the war in Yemen, and reported on homelessness in the lead-up to Harry and Meghan’s wedding in Windsor. She also once wrote a yarn on the cheese and wine version of Fyre Festival.

X

@rlangjournalist

Advert

Advert

Advert

Choose your content:

5 hours ago
7 hours ago
  • 5 hours ago

    Jurors reach partial verdict in Sean 'Diddy' Combs sex-trafficking trial

    The jury reached a partial verdict after more than 12 hours of deliberations, following weeks of disturbing testimony.

    News
  • 7 hours ago

    Archaeologists make 90 metre long Ancient Roman discovery buried on the ocean floor

    Divers excavated something in Italy that could reveal Roman-era secrets

    News
  • 7 hours ago

    'Worst shark attack ever' saw desperate crew feed dead to sharks as they circled in bloodbath

    If you've seen Jaws, then you'll know about this

    News
  • 7 hours ago

    'Infuriated' swingers speak out on the impact Diddy's 'freak-off' parties had on community

    Sean 'Diddy' Combs' lawyers caused an outcry in the swinging community

    News
  • Harvard scientists create 'brain scorecard' that tells you your risk of cancer, dementia and depression
  • Bowel cancer trial sees all patients disease-free in huge breakthrough
  • Cancer doctor shares 'common theme' she regularly sees in patients before diagnosis
  • 'Suicide pod' creator slammed over latest 'kill switch' invention for dementia patients to schedule their future death